[Complete response in a case of advanced esophageal cancer infiltrating into the main bronchus treated by chemoradiation therapy].

Yukiko Tsukao, Makoto Yamazaki, Yasuhiro Miyazaki, Tsuyoshi Takahashi, Yukinori Kurokawa, Hiroshi Miyata, Kiyokazu Nakajima, Shuji Takiguchi, Masaki Mori, Yuichiro Doki

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

We report a case of advanced esophageal cancer infiltrating into the trachea that was treated by chemoradiation therapy. The patient was a 49-year-old man who complained of dysphagia and dyspnea. Various examinations revealed an esophageal cancer with direct invasion into the trachea( cT4b[ Tr], N2[ 106recR, 106recL, 106pre, 1], M0, cStage IIIc). He underwent radiotherapy. Simultaneously, he was administered morphine to relieve dyspnea and steroid to prevent tracheal edema. From the eight day of radiation therapy, chemotherapy was initiated( DCF; docetaxe[l DTX] +cisplatin[ CDDP] + 5-fluorouracil[ 5-FU]). This chemoradiation therapy considerably reduced the esophageal tumor size. Thereafter, the patient underwent 2 additional courses of chemotherapy( FAP; 5-FU+adriamycin[ ADM] +CDDP). The therapeutic effect was judged as complete response. The patient is still alive without recurrence for 3 years and 6 months after the first treatment. There are some reports about airway stenting and adjuvant therapy for airway obstruction caused by esophageal cancer. However, there are few reports on chemoradiotherapy for esophageal cancer invading into the trachea with administration of steroids to prevent tracheal edema. We believe that this is an effective treatment.

Original languageEnglish
Pages (from-to)2124-2126
Number of pages3
JournalUnknown Journal
Volume40
Issue number12
Publication statusPublished - Jan 1 2013
Externally publishedYes

Fingerprint

Bronchi
Esophageal Neoplasms
cancer
chemotherapy
Trachea
steroid
Fluorouracil
Dyspnea
Edema
Radiotherapy
Steroids
Therapeutics
Drug Therapy
tumor
Chemoradiotherapy
Therapeutic Uses
Airway Obstruction
Deglutition Disorders
Doxorubicin
Morphine

All Science Journal Classification (ASJC) codes

  • Oncology
  • Cancer Research

Cite this

Tsukao, Y., Yamazaki, M., Miyazaki, Y., Takahashi, T., Kurokawa, Y., Miyata, H., ... Doki, Y. (2013). [Complete response in a case of advanced esophageal cancer infiltrating into the main bronchus treated by chemoradiation therapy]. Unknown Journal, 40(12), 2124-2126.

[Complete response in a case of advanced esophageal cancer infiltrating into the main bronchus treated by chemoradiation therapy]. / Tsukao, Yukiko; Yamazaki, Makoto; Miyazaki, Yasuhiro; Takahashi, Tsuyoshi; Kurokawa, Yukinori; Miyata, Hiroshi; Nakajima, Kiyokazu; Takiguchi, Shuji; Mori, Masaki; Doki, Yuichiro.

In: Unknown Journal, Vol. 40, No. 12, 01.01.2013, p. 2124-2126.

Research output: Contribution to journalArticle

Tsukao, Y, Yamazaki, M, Miyazaki, Y, Takahashi, T, Kurokawa, Y, Miyata, H, Nakajima, K, Takiguchi, S, Mori, M & Doki, Y 2013, '[Complete response in a case of advanced esophageal cancer infiltrating into the main bronchus treated by chemoradiation therapy].', Unknown Journal, vol. 40, no. 12, pp. 2124-2126.
Tsukao Y, Yamazaki M, Miyazaki Y, Takahashi T, Kurokawa Y, Miyata H et al. [Complete response in a case of advanced esophageal cancer infiltrating into the main bronchus treated by chemoradiation therapy]. Unknown Journal. 2013 Jan 1;40(12):2124-2126.
Tsukao, Yukiko ; Yamazaki, Makoto ; Miyazaki, Yasuhiro ; Takahashi, Tsuyoshi ; Kurokawa, Yukinori ; Miyata, Hiroshi ; Nakajima, Kiyokazu ; Takiguchi, Shuji ; Mori, Masaki ; Doki, Yuichiro. / [Complete response in a case of advanced esophageal cancer infiltrating into the main bronchus treated by chemoradiation therapy]. In: Unknown Journal. 2013 ; Vol. 40, No. 12. pp. 2124-2126.
@article{a195842269834e668009fb914e78c7cc,
title = "[Complete response in a case of advanced esophageal cancer infiltrating into the main bronchus treated by chemoradiation therapy].",
abstract = "We report a case of advanced esophageal cancer infiltrating into the trachea that was treated by chemoradiation therapy. The patient was a 49-year-old man who complained of dysphagia and dyspnea. Various examinations revealed an esophageal cancer with direct invasion into the trachea( cT4b[ Tr], N2[ 106recR, 106recL, 106pre, 1], M0, cStage IIIc). He underwent radiotherapy. Simultaneously, he was administered morphine to relieve dyspnea and steroid to prevent tracheal edema. From the eight day of radiation therapy, chemotherapy was initiated( DCF; docetaxe[l DTX] +cisplatin[ CDDP] + 5-fluorouracil[ 5-FU]). This chemoradiation therapy considerably reduced the esophageal tumor size. Thereafter, the patient underwent 2 additional courses of chemotherapy( FAP; 5-FU+adriamycin[ ADM] +CDDP). The therapeutic effect was judged as complete response. The patient is still alive without recurrence for 3 years and 6 months after the first treatment. There are some reports about airway stenting and adjuvant therapy for airway obstruction caused by esophageal cancer. However, there are few reports on chemoradiotherapy for esophageal cancer invading into the trachea with administration of steroids to prevent tracheal edema. We believe that this is an effective treatment.",
author = "Yukiko Tsukao and Makoto Yamazaki and Yasuhiro Miyazaki and Tsuyoshi Takahashi and Yukinori Kurokawa and Hiroshi Miyata and Kiyokazu Nakajima and Shuji Takiguchi and Masaki Mori and Yuichiro Doki",
year = "2013",
month = "1",
day = "1",
language = "English",
volume = "40",
pages = "2124--2126",
journal = "Quaternary International",
issn = "1040-6182",
publisher = "Elsevier Limited",
number = "12",

}

TY - JOUR

T1 - [Complete response in a case of advanced esophageal cancer infiltrating into the main bronchus treated by chemoradiation therapy].

AU - Tsukao, Yukiko

AU - Yamazaki, Makoto

AU - Miyazaki, Yasuhiro

AU - Takahashi, Tsuyoshi

AU - Kurokawa, Yukinori

AU - Miyata, Hiroshi

AU - Nakajima, Kiyokazu

AU - Takiguchi, Shuji

AU - Mori, Masaki

AU - Doki, Yuichiro

PY - 2013/1/1

Y1 - 2013/1/1

N2 - We report a case of advanced esophageal cancer infiltrating into the trachea that was treated by chemoradiation therapy. The patient was a 49-year-old man who complained of dysphagia and dyspnea. Various examinations revealed an esophageal cancer with direct invasion into the trachea( cT4b[ Tr], N2[ 106recR, 106recL, 106pre, 1], M0, cStage IIIc). He underwent radiotherapy. Simultaneously, he was administered morphine to relieve dyspnea and steroid to prevent tracheal edema. From the eight day of radiation therapy, chemotherapy was initiated( DCF; docetaxe[l DTX] +cisplatin[ CDDP] + 5-fluorouracil[ 5-FU]). This chemoradiation therapy considerably reduced the esophageal tumor size. Thereafter, the patient underwent 2 additional courses of chemotherapy( FAP; 5-FU+adriamycin[ ADM] +CDDP). The therapeutic effect was judged as complete response. The patient is still alive without recurrence for 3 years and 6 months after the first treatment. There are some reports about airway stenting and adjuvant therapy for airway obstruction caused by esophageal cancer. However, there are few reports on chemoradiotherapy for esophageal cancer invading into the trachea with administration of steroids to prevent tracheal edema. We believe that this is an effective treatment.

AB - We report a case of advanced esophageal cancer infiltrating into the trachea that was treated by chemoradiation therapy. The patient was a 49-year-old man who complained of dysphagia and dyspnea. Various examinations revealed an esophageal cancer with direct invasion into the trachea( cT4b[ Tr], N2[ 106recR, 106recL, 106pre, 1], M0, cStage IIIc). He underwent radiotherapy. Simultaneously, he was administered morphine to relieve dyspnea and steroid to prevent tracheal edema. From the eight day of radiation therapy, chemotherapy was initiated( DCF; docetaxe[l DTX] +cisplatin[ CDDP] + 5-fluorouracil[ 5-FU]). This chemoradiation therapy considerably reduced the esophageal tumor size. Thereafter, the patient underwent 2 additional courses of chemotherapy( FAP; 5-FU+adriamycin[ ADM] +CDDP). The therapeutic effect was judged as complete response. The patient is still alive without recurrence for 3 years and 6 months after the first treatment. There are some reports about airway stenting and adjuvant therapy for airway obstruction caused by esophageal cancer. However, there are few reports on chemoradiotherapy for esophageal cancer invading into the trachea with administration of steroids to prevent tracheal edema. We believe that this is an effective treatment.

UR - http://www.scopus.com/inward/record.url?scp=84897019619&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84897019619&partnerID=8YFLogxK

M3 - Article

C2 - 24394034

AN - SCOPUS:84897019619

VL - 40

SP - 2124

EP - 2126

JO - Quaternary International

JF - Quaternary International

SN - 1040-6182

IS - 12

ER -